Antisense Ki-67 cDNA transfection reverses the tumorigenicity and induces apoptosis in human breast cancer cells

Cancer Invest. 2008 Oct;26(8):830-5. doi: 10.1080/07357900801941878.

Abstract

Effects of antisense Ki-67 cDNA transfection on breast cancer cells were investigated in this study. Transfection of antisense Ki-67 cDNA resulted in a 70%-80% reduction in proliferation of MDA-MB-435s, cells which highly expressed Ki-67 mRNA and protein. Transwell assay showed that mobility and invasion capability was dramatically inhibited by 50%-60%, and cell cycle analysis displayed a higher proportion in G(2)/M and G(0)/G(1) phases accompanied by remarkably increased ratio of apoptotic cells. Our results suggested that antisense Ki-67 cDNA vector treatment might be an important potential option in the anticancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / pathology*
  • Cell Cycle
  • Cell Division
  • Cell Line, Tumor / pathology
  • Cell Movement
  • DNA, Antisense / genetics
  • DNA, Complementary / genetics
  • Estrogens
  • Humans
  • Ki-67 Antigen / genetics
  • Ki-67 Antigen / physiology*
  • Neoplasm Invasiveness
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / physiology*
  • Neoplasms, Hormone-Dependent / pathology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • RNA, Neoplasm / biosynthesis
  • RNA, Neoplasm / genetics
  • Recombinant Fusion Proteins / physiology
  • Transfection

Substances

  • DNA, Antisense
  • DNA, Complementary
  • Estrogens
  • Ki-67 Antigen
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Recombinant Fusion Proteins